HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tobias Schürholz Selected Research

Pep19-2.5 peptide

2/2021Anti-Infective and Anti-Inflammatory Mode of Action of Peptide 19-2.5.
1/2021A Synthetic Peptide Designed to Neutralize Lipopolysaccharides Attenuates Metaflammation and Diet-Induced Metabolic Derangements in Mice.
1/2020The synthetic LPS binding peptide 19-2.5 interferes with clotting and prevents degradation of high molecular weight kininogen in plasma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tobias Schürholz Research Topics

Disease

13Sepsis (Septicemia)
01/2022 - 09/2010
5Septic Shock (Toxic Shock Syndrome)
06/2021 - 09/2010
3Inflammation (Inflammations)
01/2022 - 01/2015
3Infections
01/2022 - 02/2015
3Endotoxemia
01/2020 - 03/2013
2Bacterial Infections (Bacterial Infection)
01/2019 - 08/2015
2Shock
01/2015 - 09/2010
1Critical Illness (Critically Ill)
06/2021
1Obesity
01/2021
1Fatty Liver
01/2021
1Hypercholesterolemia
01/2021
1Insulin Resistance
01/2021
1Proteinuria
01/2021
1Hyperlactatemia
04/2015
1Hemorrhagic Shock
02/2015
1Bacteremia
03/2013
1Multiple Organ Failure (MODS)
09/2010

Drug/Important Bio-Agent (IBA)

7Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 09/2010
6Peptides (Polypeptides)IBA
02/2021 - 09/2010
3Pharmaceutical PreparationsIBA
02/2021 - 03/2013
3Pep19-2.5 peptideIBA
02/2021 - 01/2020
3EndotoxinsIBA
09/2015 - 09/2010
2LipopolysaccharidesIBA
02/2021 - 09/2015
2Lipoproteins (Lipoprotein)IBA
02/2021 - 09/2015
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
02/2021 - 01/2015
2Local Anti-Infective Agents (Antiseptics)IBA
03/2013 - 09/2010
1Biomarkers (Surrogate Marker)IBA
01/2022
1SolutionsIBA
06/2021
1Crystalloid SolutionsIBA
06/2021
1ElectrolytesIBA
06/2021
1Adenosine Monophosphate (AMP)IBA
01/2021
1Phosphotransferases (Kinase)IBA
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2021
1InflammasomesIBA
01/2021
1AnticoagulantsIBA
01/2020
1Antimicrobial PeptidesIBA
01/2019
1Norepinephrine (Noradrenaline)FDA LinkGeneric
04/2015
1Lactic Acid (Lactate)FDA LinkGeneric
04/2015
1Ibuprofen (Motrin)FDA LinkGeneric
01/2015
1Therapeutic UsesIBA
01/2015
1Virulence Factors (Pathogenicity Factors)IBA
03/2013
1CytokinesIBA
09/2010
1Glucose (Dextrose)FDA LinkGeneric
09/2010

Therapy/Procedure

4Therapeutics
08/2015 - 09/2010
3Critical Care (Surgical Intensive Care)
01/2022 - 01/2015
2Resuscitation
01/2019 - 01/2015
1Medicine Chests (Medicine Chest)
01/2015
1Punctures
03/2013
1Ligation
03/2013